Advanced search
Publication Cover
Journal of Medical Economics Volume 26, 2023 - Issue 1
Submit an article Journal homepage
1,449
Views
2
CrossRef citations to date
0
Altmetric
Respiratory Medicine

Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey

Deniz Tugaya Rights of Patients Department, Ankara City Hospital, Ankara, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7032-0876
ORCID Icon,
Mehmet Topb Department of Health Management, Faculty of Economics and Administrative Sciences, Hacettepe University, Ankara, Turkey
,
Ömür Aydinc Division of Immunology and Allergy, Department of Pulmonary Diseases, School of Medicine, Ankara University, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-3670-1728
ORCID Icon,
Sevim Bavbekc Division of Immunology and Allergy, Department of Pulmonary Diseases, School of Medicine, Ankara University, Ankara, Turkey
,
Ebru Damadoğlud Division of Immunology and Allergy, Department of Pulmonary Diseases, School of Medicine, Hacettepe University, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0001-6250-2100
ORCID Icon,
Ferda Öner Erkekole Division of Immunology and Allergy, Department of Pulmonary Diseases, School of Medicine, Yildirim Beyazit University, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0001-9155-0304
ORCID Icon,
Ilkay Koca Kalkanf Division of Immunology and Allergy, Department of Pulmonary Diseases, Ankara Atatürk Sanatorium Research and Training Hospital, Ankara, Turkey
,
A. Fuat Kalyoncud Division of Immunology and Allergy, Department of Pulmonary Diseases, School of Medicine, Hacettepe University, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0001-7475-3775
ORCID Icon,
Gül Karakayad Division of Immunology and Allergy, Department of Pulmonary Diseases, School of Medicine, Hacettepe University, Ankara, Turkey
,
I. Kivilcim Oğuzülgeng Department of Pulmonary Diseases, School of Medicine, Gazi University, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-0535-5455
ORCID Icon,
Haluk Türktaşg Department of Pulmonary Diseases, School of Medicine, Gazi University, Ankara, Turkey
&
Ivo Abrahamh Center for Health Outcomes and PharmacoEconomic Research, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USAORCID Iconhttps://orcid.org/0000-0002-5224-4977
ORCID Icon show all
Pages 720-730 | Received 17 Feb 2023, Accepted 28 Apr 2023, Published online: 24 May 2023

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jefferson Antonio Buendía, Diana Guerrero Patiño & Andrés Felipe Zuluaga Salazar. Cost effectiveness of omalizumab for severe asthma in Colombia. Journal of Asthma 0:0, pages 1-8.
Read now

Articles from other publishers (1)

Pamir ÇERÇİ & Tuba ERDOĞAN. (2023) Real-Life Data on the Use of Omalizumab in Patients with Severe Asthma and Chronic Urticaria and Mepolizumab in Patients with Severe Asthma: A Retrospective StudyAstım ve Kronik Ürtikerli Hastalarda Omalizumab'ın ve Şiddetli Astım Hastalarında Mepolizumab'ın Kullanımına İlişkin Gerçek Yaşam Verileri: Geriye Dönük Bir Çalışma. OSMANGAZİ JOURNAL OF MEDICINE 45:6.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.